UnityPoint Health Ventures

UnityPoint Health Ventures, established in 2019, serves as the corporate venture capital arm of UnityPoint Health, located in West Des Moines, Iowa. The organization is dedicated to investing in early-stage companies within various sectors, including healthcare, digital therapeutics, information technology, tech-enabled services, medical devices, and diagnostics. Its Innovation Venture Fund focuses on identifying financial and strategic investment opportunities that enhance the patient and provider experience. By partnering with innovative ideas and companies, UnityPoint Health Ventures aims to contribute to advancements in the healthcare landscape.

Austin Duke

Venture Investing Director

Erin Templeton

Innovation Associate

Anthony Zlaket

Venture Associate

13 past transactions

Pathware

Series A in 2022
Pathware Inc. is a company that manufactures automated point-of-care biopsy assessment systems, primarily through its product Bioptic. This system enables clinicians and technicians to diagnose pathogens and provides a complete slide imaging and sample management platform designed to enhance pathology workflows. By simplifying the process and reducing repetition, Pathware aims to improve the efficiency of pathologists while maintaining high standards of care. Established in 2017 and headquartered in Ann Arbor, Michigan, with a second location in Seattle, Washington, Pathware was formerly known as MedKairos, Inc. The company is committed to developing intuitive hardware and software solutions that facilitate critical diagnostic processes.

b.well Connected Health

Series B in 2021
b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for consumer engagement, holistic health management, and cost containment. It specializes and supports health plans, health systems, employers and pharmaceutical companies. The company was founded in 2015 and headquartered in Baltimore, Maryland.

TailorMed

Venture Round in 2021
TailorMed Medical Ltd. is a health technology company that specializes in financial navigation systems designed to assist patients and healthcare providers in managing medical expenses. Founded in 2017 and based in Tel Aviv, Israel, TailorMed offers a comprehensive platform that automates financial processes, identifies patients at financial risk, and connects them with tailored funding opportunities. Its key products include TailorMed Financial Navigation, which streamlines financial operations for healthcare centers; TailorMed Financial Insights, a reporting dashboard that tracks key performance indicators; and TailorMed Pharmacy, which simplifies the ordering and billing of medications based on individual treatment plans. By leveraging advanced algorithms and a robust data set, TailorMed aims to reduce patient financial toxicity and improve efficiencies throughout the treatment lifecycle.

DocStation

Seed Round in 2021
DocStation, Inc. is a cloud-based patient care platform designed to enhance the role of pharmacists in healthcare. Founded in 2017 and headquartered in Austin, Texas, the company connects pharmacists with payers to support value-based care programs. The platform allows over 500 providers to collaborate with innovative health plans, facilitating improved patient outcomes and reduced healthcare costs. It features an integrated dashboard that helps pharmacists maintain up-to-date patient information, including diagnoses, medications, immunizations, and allergies. Additionally, DocStation enables the creation of personalized care plans, monitors adherence to treatments, and schedules follow-ups, ensuring real-time connectivity between pharmacists and their patients.

SilverCloud Health

Series B in 2020
SilverCloud Health develops an online platform that delivers tailored therapeutic solutions through evidence-based digital therapies. Founded in 2011 and headquartered in Boston, Massachusetts, with additional offices in Dublin, Ireland, and London, United Kingdom, the company serves the healthcare, medical, and pharmaceutical sectors. The SilverCloud platform enables users to provide immediate access to professional support, resulting in significantly increased patient engagement and reduced program dropout rates compared to leading online therapeutic products. By offering innovative health and wellness solutions, SilverCloud Health aims to enhance the accessibility and effectiveness of mental health care.

Bright.md

Series C in 2020
Bright.md is a developer of an AI-powered virtual-care platform designed to modernize direct-to-patient telehealth for healthcare systems. The company partners with premier healthcare organizations to offer SmartExam to more than 10 million patients who are seeking convenient urgent and primary care online, connecting them to their physicians via a home computer or mobile device reducing visits, enabling patients to receive conveniently, high quality, asynchronous, online care from established and trusted health system providers. The company was founded in 2014 and is based in Portland, Oregon.

VIDA

Series C in 2020
VIDA Diagnostics, Inc. specializes in clinical imaging software and analysis services, focusing on lung and respiratory care. The company's flagship products include LungPrint, an automated AI-powered tool that analyzes chest CT scans to assess lung physiology and functional tissue, and VIDA|precision, which provides detailed lung measurements for pulmonary clinicians. Additionally, VIDA|vision enables interactive examination of advanced quantitative imaging analysis results. The company offers comprehensive image analysis services for both academic and clinical trials, including study design, CT protocol development, and data analysis. Founded in 2004 and headquartered in Coralville, Iowa, with an office in Minneapolis, VIDA's software is FDA cleared and CE-marked, making it suitable for clinical use in multiple regions, including the US, European Economic Area, Canada, and Australia. Through its innovative solutions, VIDA aims to empower healthcare organizations and physicians to enhance patient outcomes, especially for those at risk of chronic respiratory diseases such as COPD, interstitial lung disease, lung cancer, and COVID-19.

b.well Connected Health

Series A in 2020
b.well Connected Health is a health, wellness, and fitness company that provides an integrated solution for consumer engagement, holistic health management, and cost containment. It specializes and supports health plans, health systems, employers and pharmaceutical companies. The company was founded in 2015 and headquartered in Baltimore, Maryland.

CareSignal

Venture Round in 2020
CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.

Kaizen Health

Series B in 2020
Kaizen Health is a healthcare mobility company that is improving access, quality, satisfaction and efficiency in health care by removing transportation as a barrier. Top healthcare delivery systems, payers, senior living, clinical trials and municipalities are utilizing Kaizen Health’s industry-leading technology and transportation network to address social determinants of health within and outside of health care to better promote health equity.

CareSignal

Seed Round in 2019
CareSignal provides an accessible remote patient monitoring platform that improves payer and provider performance in value-based care by engaging and identifying rising-risk patients. Care teams receive real-time alerts enabling real-time prioritization and outreach, and patients respond to evidence-based questions via text messages or phone calls.

VIDA

Corporate Round in 2019
VIDA Diagnostics, Inc. specializes in clinical imaging software and analysis services, focusing on lung and respiratory care. The company's flagship products include LungPrint, an automated AI-powered tool that analyzes chest CT scans to assess lung physiology and functional tissue, and VIDA|precision, which provides detailed lung measurements for pulmonary clinicians. Additionally, VIDA|vision enables interactive examination of advanced quantitative imaging analysis results. The company offers comprehensive image analysis services for both academic and clinical trials, including study design, CT protocol development, and data analysis. Founded in 2004 and headquartered in Coralville, Iowa, with an office in Minneapolis, VIDA's software is FDA cleared and CE-marked, making it suitable for clinical use in multiple regions, including the US, European Economic Area, Canada, and Australia. Through its innovative solutions, VIDA aims to empower healthcare organizations and physicians to enhance patient outcomes, especially for those at risk of chronic respiratory diseases such as COPD, interstitial lung disease, lung cancer, and COVID-19.